Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsors
- 15
- Latest action
- Aug 13, 2026
What it does
The Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026 would require manufacturers of biomedical products developed with federal research funding to enter into agreements ensuring U.S. prices do not exceed those in other high-income economies.
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Loading recorded actions…
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.